Skip to main content
Eurosurveillance logoLink to Eurosurveillance
. 2024 Mar 14;29(11):2300521. doi: 10.2807/1560-7917.ES.2024.29.11.2300521

Regional dissemination of NDM-1 producing Enterobacter hormaechei ST1740, with a subset of strains co-producing VIM-4 or IMP-13, France, 2019 to 2022

Inès Rezzoug 1,2,3, Cécile Emeraud 1,2,3, Christophe Rodriguez 4,5,6, Jean-Michel Pawlotsky 4,5,6, Rémy A Bonnin 1,2,3, Laurent Dortet 1,2,3
PMCID: PMC10941310  PMID: 38487887

Abstract

Background

From 2019 to 2022, the French National Reference Centre for Antibiotic Resistance (NRC) received a total of 25 isolates of Enterobacter hormaechei subsp. hoffmannii sequence type (ST)1740. All produced metallo-β-lactamase(s) and were from the Lyon area.

Aim

To understand these strains’ spread and evolution, more extended microbiological and molecular analyses were conducted.

Methods

Patients’ demographics and specimen type related to isolates were retrieved. All strains underwent short-read whole genome sequencing, and for 15, long-read sequencing to understand carbapenemase-gene acquisition. Clonal relationships were inferred from core-genome single nt polymorphisms (SNPs). Plasmids and the close genetic environment of each carbapenemase-encoding gene were analysed.

Results

Patients (10 female/15 male) were on average 56.6 years old. Seven isolates were recovered from infections and 18 through screening. With ≤ 27 SNPs difference between each other’s genome sequences, the 25 strains represented a clone dissemination. All possessed a chromosome-encoded bla NDM-1 gene inside a composite transposon flanked by two IS3000. While spreading, the clone independently acquired a bla VIM-4-carrying plasmid of IncHI2 type (n = 12 isolates), or a bla IMP-13-carrying plasmid of IncP-1 type (n = 1 isolate). Of the 12 isolates co-producing NDM-1 and VIM-4, seven harboured the colistin resistance gene mcr9.2; the remaining five likely lost this gene through excision.

Conclusion

This long-term outbreak was caused by a chromosome-encoded NDM-1-producing ST1740 E. hormaechei subsp. hoffmannii clone, which, during its dissemination, acquired plasmids encoding VIM-4 or IMP-13 metallo-β-lactamases. To our knowledge, IMP-13 has not prior been reported in Enterobacterales in France. Epidemiological and environmental investigations should be considered alongside microbiological and molecular ones.

Keywords: carbapenemase, NDM, VIM, IMP, β-lactamase, Enterobacterales


Key public health message.

What did you want to address in this study?

Metallo-β-lactamases (MBL) called NDM-1, VIM-4 and IMP-13 can make bacteria resistant to many antibiotics. MBL are encoded by bla genes on chromosomes or plasmids. Whereas several bacterial species can harbour NDM-1 and VIM-4, IMP-13 mainly occurs in the Pseudomonas aeruginosa species, found in the environment. We investigated a French regional outbreak due to an NDM-1-producing strain of the species Enterobacter hormaechei.

What have we learnt from this study?

An E. hormaechei of subspecies hoffmannii ST1740 clone, with a chromosome-encoded bla NDM-1 caused the outbreak between 2019 and 2022, which happened in hospitals of the Lyon area. When spreading, the clone independently acquired bla VIM-4 or bla IMP-13 on respective IncHI2- and IncP-1-type plasmids. Enteric E. hormaechei can occur in the environment, so plasmid transfer between P. aeruginosa and the clone may have happened.

What are the implications of your findings for public health?

E. hormaechei subsp. hoffmannii belongs to the order of the Enterobacterales. Prior to this outbreak, IMP-13-producing Enterobacterales had not been observed in France. The outbreak source was probably in the environment, and environmental reservoirs should be considered in long-term outbreaks. Our findings highlight the need for epidemiological and environmental investigations to complement molecular and microbiological findings.

Introduction

Carbapenems are often considered as last-resort antibiotics for the treatment of infections caused by Gram-negative bacilli. Since 2010, however, the prevalence of carbapenem-resistant Enterobacterales (CPE) has dramatically increased, mostly due to the global dissemination of carbapenemase producers [1].

Genes encoding carbapenemases are mainly carried on plasmids. Carbapenemases have been identified in three (A, B, D) of the four (A−D) classes of the Ambler classification. Carbapenemases of Ambler class A are mainly represented by Klebsiella pneumoniae carbapenemase (KPC) enzymes, which occur worldwide (mostly in China, Greece, Italy, South America and the United States) [2]. The majority of the Ambler class B enzymes, also named metallo-β-lactamases (MBLs), are represented by New Delhi MBLs (NDM)-, Verona integron-encoded MBLs (VIM)- and imipenemases (IMP). VIM producers are highly prevalent in Italy and Greece, while IMP producers are mostly reported from China, Japan and Australia. NDM producers, which originated from India have now disseminated globally [2]. Finally, in the west of Europe (including France), the most prevalent carbapenemases in Enterobacterales are oxallicinase (OXA)-48-like enzymes that belong to the Ambler class D.

Contrary to Ambler class A and D carbapenemases, that possess an active serine in their catalytic site, class B carbapenemases (MBLs) require the binding of two zinc ions inside this site to be active [3]. MBLs are resistant to all commercially available β-lactamase inhibitors such as avibactam, clavulanic acid, relebactam, sulbactam, tazobactam and vaborbactam and hydrolyse all β-lactams except aztreonam. Unfortunately, MBL-producing strains frequently also produce extended-spectrum β-lactamases (ESBL) or over-express cephalosporinase, leading in both cases to successful aztreonam hydrolysis and to highly difficult-to-treat strains.

In France, during the last decade, Enterobacter cloacae complex (ECC) was often reported as the third most prevalent species among CPE behind Escherichia coli and K. pneumoniae [4]. ECC have been described to be ubiquitous in the environment and commensal enteric bacteria in humans [5]. However, they are also reported as opportunistic pathogens responsible for hospital-acquired infections [6]. Currently the ECC includes 19 species and six subspecies. These species are difficult to differentiate, because the most common identification method used in clinical microbiology, matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF), cannot efficiently discriminate them. Despite this, E. hormaechei subsp. hoffmannii has been reported as the most prevalent species among clinical and environmental ECC isolates [7,8].

The spread of carbapenemases within Enterobacterales is a common phenomenon associated with outbreaks. An example is the dissemination of several species of VIM-4 producing ECC in the Lyon area, which has been reported since 2015 [8]. Carbapenemases are also found in other Gram-negative bacilli such as Pseudomonas aeruginosa. Accordingly, IMP-13 has been reported nearly exclusively in P. aeruginosa isolates that have spread worldwide [9].

In this study, we investigated the dissemination in the Lyon area of ST1740 E. hormaechei subsp. hoffmannii isolates producing NDM-1 that were received from 2019 to 2022 at the Kremlin-Bicêtre French National Reference Centre (F-NRC) for antimicrobial resistance in carbapenemase-producing Enterobacterales.

Methods

Testing for carbapenemase production

All isolates referred to the F-NRC are assessed for carbapenemase production with the Carba NP and NG Carba5 assays (NG Biotech, Guipry, France) as previously described [10,11]. Antimicrobial susceptibility testing is performed by disc diffusion on Mueller−Hinton agar (Bio-Rad, Marne la Coquette, France) and minimum inhibitory concentration (MIC) is determined by broth microdilution (ThermoFisher, Sensititre, France). In the current study, antimicrobial susceptibility results were interpreted according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines as updated in 2023 [12].

Whole genome sequencing, species confirmation and typing

For all carbapenemase producers identified at the F-NRC, whole genome sequencing (WGS) is conducted using the NextSeq500 system (Illumina technology) according to the manufacturer’s instructions. De novo assembly is performed with CLC Genomic Workbench v12,0 (QIAGEN, Les Ulis, France).

After MALDI-TOF, WGS data are employed to confirm the bacterial species, using Centrifuge Taxonomic Classifier 1.0.3 (https://github.com/chienchi/kbase-centrifuge).

Multilocus sequence typing (MLST) analysis is performed using MSLT 2.0 server (https://cge.cbs.dtu.dk/services/MLST/).

Selection of bacterial isolates for the study

From 2019 to 2022, a total of 3,208 ECC isolates were received by the F-NRC (821, 692, 784 and 911 in 2019, 2020, 2021 and 2022, respectively), including 415 NDM producers (63, 71, 117, 164 in 2019, 2020, 2021 and 2022, respectively). Among the latter, 25 E. hormaechei subsp. hoffmannii clinical isolates of ST1740, which produced NDM-1, were included in the study. All these NDM-1-producing isolates originated from the Lyon area, France. Patient data such as age, sex (collected as binary variable: male/female), and hospitalisation ward were available with the isolates as well as information regarding the clinical sample (e.g. specimen type and date of isolation).

Single nucleotide polymorphisms and phylogenetic analyses

The isolates included in the study were investigated using single nt polymorphisms (SNP) analysis. For this, sequence reads were mapped to a reference genome (GCF_001729745_ehormaechei_hoffmannii) using SNIppy v4.6.0 (https://software.cqls.oregonstate.edu/updates/snippy-4.6.0/). Metadata and phylogenetic trees (inferred by neighbour-joining method) were visualised using iTOL v6.5.2 (https://itol.embl.de/).

Identification of antimicrobial resistance genes and plasmids

ResFinder server v4.0 (https://cge.cbs.dtu.dk/services/ResFinder/) was used to identify acquired antimicrobial resistance genes and PlasmidFinder (https://cge.cbs.dtu.dk/services/PlasmidFinder/) to detect plasmid replicon types.

Long read sequencing

Of the 25 isolates included in the study, long read sequencing was performed on 15. The latter had been selected to cover each subcluster or individual branch of the tree determined by phylogenetic analysis. The sequencing was achieved with Oxford Nanopore MinION technology (Oxford Nanopore, Oxford, United Kingdom), as previously described [13], to decipher the genomic localisation (chromosome of plasmid) of carbapenemase-encoding genes, and to analyse the genetic environment surrounding these genes.

Plasmids characterisation

Plasmids were reconstructed by combining Illumina and MinION sequencing data using Unicycler (v0.5.0). The assembled sequences were annotated using the Rapid Annotations using Subsystems Technology (RAST) server (rast.nmpdr.org). Integrons were classified according to INTEGRALL (http://intergrall.bio.ua.pt/) [14] and ISFinder (https://isfinder.biotoul.fr/blast.php). Plasmids’ visualisation was realised using the Proksee software (https://proksee.ca/).

Conjugation experiments

Conjugation experiments were performed as previously described using the azide resistant E. coli J53 as recipient strain [15]. Transconjugants were selected on ticarcillin (50 μg/mL) and azide (100 μg/mL) supplemented agar plates.

Results

Patients’ characteristics

Of the 25 strains of ST1740 E. hormaechei subsp. hoffmanni received at the French NRC between 2019 and 2022, 10 were isolated from female and 15 from male patients. The average age of the patients was 56.6 years, and the median age was 65 years. Among the total 25 ST1740 ECCs strains, 18 were recovered from screening samples. The remainder seven were isolated because they were responsible for infections, including urinary tract infections (n = 2), bacteraemia (n = 1) and respiratory tract infections (n = 3). Among the respiratory tract infections, strains were isolated from bronchoalveolar lavage (n = 1), bronchial aspirations (n = 2) and sputum (n = 1). Infected or colonised patients were localised in the same geographical area, Lyon area (France), but hospitalised in three different hospital/departments. In detail, 18/25 were hospitalised at Hospital 1 in the infection disease department (n = 1), haematology department (n = 1), intensive care unit (ICU) (n = 2), paediatric cardiac resuscitation unit (n = 3), pneumology unit (n = 3), geriatric unit (n = 1), cardiology unit (n = 1) and adult surgery unit (n = 1), respectively. No data were available about the clinical ward for the last five patients hospitalised at Hospital 1. Three clinical strains were recovered from patients hospitalised at Hospital 2 (orthopaedics (n = 1) and ear, nose, and throat (n = 2) departments). Two isolates were from patients hospitalised at Hospital 3 in the ICU and rehabilitation care unit, respectively. Finally, two clinical isolates were cultured by two French private laboratories of the Lyon area from samples of patients who were no longer hospitalised; information on the hospitals where these patients had been prior admitted was not available.

Long-term regional outbreak of NDM-1 +/− VIM-4 or IMP-13-producing Enterobacter hormaechei

All 25 strains were resistant to penicillin and their derivatives, and to 1st, 2nd, 3rd and 4th generation cephalosporins. β-lactamase inhibitors such as avibactam had no effect. MICs of imipenem and meropenem ranged from 1 to > 8 mg/L and from 1 to 16 mg/L, respectively. A total of 12 strains produced NDM-1 only and were isolated from patients hospitalised in the three different hospitals. This first group of strains included the oldest isolate which had been isolated in the first half of 2019 in Hospital 1 and strains in the group continued to be detected throughout the study period. Twelve other strains isolated from the three hospitals coproduced NDM-1 and VIM-4. The earliest isolate of this kind had been received by the F-NRC in the first half of 2020, with more such isolates until 2022. The last isolate coproduced NDM-1 and IMP-13 and had been isolated from Hospital 2 in the second half of 2022. The common resistome to all groups was composed of the carbapenemase-encoding bla NDM-1 gene, the intrinsic cephalosporinase encoding bla ACT-5 gene, and resistance determinants to aminoglycosides (aph(3’)-VI), fosfomycin (fosA) and trimethoprim (dfrA15) (Figure 1A). In addition to this common genome, the 12 VIM-4 producers also carried bla TEM-1, ant(2”)-Ia, aac(6')-Il, aadA2, qnrA1, sul1, dfrA1 and tet(A). Of note, among these 12 VIM-4 producers, seven had acquired the colistin resistance gene mcr-9.2 including two that additionally acquired aac(6')-Ib3. Regarding the producer of NDM-1 and IMP-13, only the bla IMP-13 and aac(6')-Ib3 genes, respectively encoding IMP-13 and conferring aminoglycoside resistance were added to the common resistome (Figure 1A).

Figure 1.

(A) Isolates’ origin, microbiological and molecular characteristics and (B) relationships between strains of NDM-1-producing Enterobacter hormaechei ST1740 analysed at the National Reference Centre for carbapenemase-producing Enterobacteriaceae, France, 2019−2022 (n = 25 isolates)

NDM: New Delhi metallo-β-lactamase; SNP: single nucleotide polymorphism; ST: sequence type.

A. Isolates’ origin, microbiological and molecular characteristics. A neighbour-joining phylogenetic tree is presented, with for each leaf, the date of strain isolation indicated in the first column (red for older strains to blue for more recent ones). The ‘+’ sign indicates MinION sequencing in the first column of the table. The presence of antimicrobial resistance determinants and plasmids are indicated in black for each strain. An SNP matrix is presented, with comparisons of strains in terms of differences in numbers of SNPs between them; those forming clusters in the phylogenetic tree are boxed.

B. Neighbour-joining phylogenetic tree of carbapenemase-producing ST1740 E. hormaechei. Clusters (α, β, γ, δ, ε) are circled. The distance between two strains is proportional to the number of SNPs. This number of SNPs is indicated on each line.

Figure 1

Since all NDM-1 +/− VIM-4 or IMP-13-producing E. hormaechei subsp. hoffmannii belonged the same sequence type (ST), we used a core genome SNP-based approach to create a phylogenetic tree (Figure 1). The maximum number of SNPs observed between two strains was of 27, suggesting that all these isolates were part of the same cluster that disseminated from January 2019 to September 2022. The comparison of SNPs numbers with spatio-temporal data of patients led us to identify five (α, β, δ, ε, γ) probable independent patient-to-patient transmission routes (Figure 1) corresponding to 17 isolates for which the number of SNPs were very low (0 to 8 SNPs). Phylogenetic investigations suggested a common source for all these isolates, which we were not able to definitively identify. However, the presence of bla IMP-13 (which is always reported in P. aeruginosa) suggests that E. hormaechei subsp. hoffmannii NDM-1 might have been present in the environment or contaminated it. Through an environmental route, this strain may also have come into contact with VIM-4-producing ECC that have been described to be highly prevalent in Lyon area since 2015 [8]. This scenario implies the transfer of bla IMP-13 or bla VIM-4-carrying plasmids in the ST1740 NDM-1-producing E. hormaechei subsp. hoffmannii. To confirm this hypothesis and characterise bla IMP-13 and bla VIM-4-carrying plasmids, long-read sequencing and conjugation experiments were performed.

Characterisation of bla NDM-1 localisation and genetic context

Whole-genome sequencing using a long-read technology was performed on 15 strains representative of all the sub-clusters identified this study (Figure 1A). The combination of long-read and short-read techniques allowed to reconstitute the chromosome of the ST1740 isolate, which was found to have a total length of ca 4,827,000 bp. The previously described common resistome of the 25 isolates was chromosome encoded, including bla NDM-1 which was carried on a composite transposon bracketed by two insertion sequences (IS)3000 in all sequenced strains (Figure 2).

Figure 2.

Linear map of the close genetic environment of the chromosome-encoded bla NDM-1 gene in an Enterobacter hormaechei ST1740 strain analysed at the National Reference Centre for carbapenemase-producing Enterobacteriaceae, France, 2019−2022

HP: hypothetical protein; IS: insertion sequence; NDM: New Delhi metallo-β-lactamase; PRAI: phosphoribosylanthranilate isomerase; ST: sequence type.

The carbapenemase-encoding gene is represented in red. The other antimicrobial resistance determinants are represented in green. Insertion sequences (IS) are represented in grey. The ble MBL gene responsible to bleomycin resistance and systematically found downstream bla NDM is represented in purple.

Figure 2

Plasmids’ characterisation of ST1740 Enterobacter hormaechei subspecies hoffmannii

Replicases of several plasmids were identified in all the strains of this collection. IncFIB and col(pHAD28) replicases were observed in all strains, whereas IncHI2 was found only in the VIM-4-producing isolates (n = 12) and IncP-1 in the IMP-13-producing strain.

Combination of long-read and short-read sequencing allowed to characterise these four plasmids. The col(pHAD28) plasmid was 2,495 bp and did not carry any resistance gene. The IncFIB plasmid was 112,496 bp and carried dfrA1, dfrA15 and sul1 genes conferring resistance to trimethoprim and sulfamethoxazole (Figure 3A).

Figure 3.

Circular representation of (A) an incFIB plasmid, (B) a bla VIM-4-carrying IncH2 plasmid and (C) a bla IMP-13-carrying IncP-1 plasmid found in Enterobacter hormaechei ST1740 strains analysed at the National Reference Centre for carbapenemase-producing Enterobacteriaceae, France, 2019−2022

CDS: coding sequence.

The representation was performed using Proksee software. Resistance genes are represented by red arrows. The tra genes implicated in plasmid self-conjugation are coloured in green. Other coding sequences are represented by purple arrows. The mcr9.2 localisation into the bla VIM-4-carrying IncH2 plasmid is indicated under the panel B.

Figure 3

The bla VIM-4-carrying incHI2 plasmid was 298,456 bp in size. On this plasmid, the bla VIM-4 gene was located at the first position of a class 1 integron (In416) with aacA7, dfrA1b and aadA1b (Figure 3B). This plasmid also carried bla TEM-1, ant(2”)-Ia, tet(A), aac(6’)-Ib3, and qnrA1. Among the 12 incHI2 plasmid-carrying strains, seven additionally harboured the mcr9–2 gene. This gene, responsible for colistin resistance, was integrated between two IS: IS903B and a truncated IS1R (Figure 3B). The five isolates that did not carry mcr9.2 nevertheless kept IS903B and IS1R, suggesting an excision of mcr9.2 from the IncHI2 plasmid in these strains. The incHI2 plasmids contained a transfer module (tra genes) involved in conjugation. Self-conjugation abilities were confirmed by transferring these plasmids in an E. coli J53 recipient strain.

Finally, IncP-1-type plasmid was of 52,000 bp in size and carried the bla IMP-13 gene. A similar (98.2% identity) IncP-1-type plasmid lacking the bla IMP-13 gene was previously described in P. aeruginosa (GenBank accession number: CP072561). This MBL encoding gene was bracketed by aac(6’)-Ib3 (represented as aac(6’)-Ib on Figure 3C) conferring resistance to aminoglycosides, and the fosX gene conferring resistance to fosfomycin. Again, self-conjugation abilities conferred by the transfer module (tra genes) were confirmed experimentally.

Discussion

This study provides molecular and microbiological characteristics of ST1740 E. hormaechei subsp. hoffmannii isolates that were involved in a long-term outbreak and that produced multiple carbapenemases. In all the 25 isolates of this outbreak, the bla NDM-1 gene was located on the chromosome. Although bla NDM-1 is most often reported as plasmid encoded in Enterobacterales, a chromosomal location of bla NDM has already been described in E. coli [16], Proteus mirabilis [17], K. pneumoniae [18], and P. vulgaris [19], but never in ECC. Usually, mobile genetic elements carrying bla NDM are derivatives from Tn125 [20,21]. In the ST1740 outbreak clone, the bla NDM-1 gene was embedded into a composite transposon, Tn3000 composed of two IS3000 inserted inside a chromosome-encoded copy of this fossilised Tn125 [22]. Remarkably, this bla NDM-1-carryingTn3000 has been previously described on IncX3 and IncFIIκ plasmids in E. coli and in E. hormaechei subsp. hoffmannii, respectively [23].

Of note, VIM-4-producing ECC have been demonstrated to be endemic in the geographic area where the current outbreak took place since 2015 [8]. As observed in our ST1740 E. hormaechei subsp. hoffmannii clone, bla VIM-4 was most often carried on an IncHI2 plasmid inside a In416 integron [8].

The bla IMP-13-carrying IncP-1 plasmid displayed 98.2% identity with pBYT1–2 plasmid (GenBank accession number: CP072561) recovered from P. aeruginosa. The difference between these two plasmids is in the acquisition of bla IMP-13, aac(6’)-Ib and fos(X) as integron cassette genes. First reported in Italy [24], bla IMP-13 has disseminated in P. aeruginosa worldwide [18] and is rarely described in Enterobacterales. To our knowledge, this is the first report of an IMP-13-producing Enterobacter spp. in France.

Our genomic analysis combined with spatio-temporal data of patients highlighted a probable environmental source containing NDM-1-producing ST1740 E. hormaechei subsp. hoffmannii. The outbreak clone could have possibly spread via patients and/or environmental contamination and come into contact with VIM-4 producing ECC or IMP-13-producing P. aeruginosa. Since both bla VIM-4 and bla IMP-13-carrying plasmids have been demonstrated to be self-conjugative, we might hypothesise that bla VIM-4-carrying incHI2 plasmid and bla IMP-13-carrying IncP plasmid were transferred independently from endemic VIM-4-producing ECC and IMP-13-producing P. aeruginosa into the NDM-1-producing ST1740 E. hormaechei subsp. hoffmannii clone. Then, as shown in Figure 1B, all strains inside each sub-clusters are closely related suggesting that patient-to-patient transmission might have occurred independently with NDM-1, or NDM-1 together with VIM-4-producing ST1740 E. hormaechei subsp. hoffmannii. As previously described [25], environmental reservoirs such as toilets and tanks have to be considered in the spread of the clone in this long-term outbreak. Containment of such an outbreak requires not only strict infection control measures, but also an intensive cleaning process (descaling and bleaching) and sometimes material (toilets, tanks) replacement [25]. The F-NRC communicated its findings to the concerned hospitals.

A main limitation of this work is that the outbreak description is the result of a retrospective molecular analysis, and environmental investigations were not carried out to identify the source. Moreover, limited information was available on epidemiological links. In addition, this study is based on E. hormaechei subsp. hoffmannii strains received at the F-NRC, which may not constitute the complete set of isolates involved in the outbreak, since submission to F-NRC of bacterial isolates by clinical laboratories is done on a voluntary basis. Accordingly, even though no new E. hormaechei subsp. hoffmannii strains producing NDM-1 +/ − VIM-4 or IMP-13 have been received since September 2022, we cannot rule out that the environmental source has been removed and that the outbreak is not still silently active.

Conclusion

In this study, we described a long-term regional outbreak of chromosome encoded NDM-1-producing ST1740 E. hormaechei subsp. hoffmannii that subsequently acquired plasmid encoded VIM-4 or IMP-13 metallo-β-lactamases. This outbreak most probably involved environmental contamination where plasmid transfers occurred between this NDM-1-producing ST1740 E. hormaechei subsp. hoffmannii, endemic VIM-4-producing ECC and IMP-13-producing P. aeruginosa. To our knowledge, IMP-13, which mainly disseminates in P. aeruginosa has not been previously reported in Enterobacterales in France. Our results highlight the crucial need of environmental and epidemiological investigations to complement both microbiological analyses and whole genome comparisons, in order to more comprehensively elucidate outbreaks.

Ethical statement

Ethical approval was not necessary, as outbreak investigation is part of routine surveillance tasks of both local and national French Public Health Authorities.

Data availability

The complete chromosome sequences of the 25 E. hormaechei subsp. hoffmannii isolates were submitted to GenBank under BioProject number PRJN927207. The complete sequences of the plasmids IncFIb, IncP-1 and IncH2b identified in our collection were submitted to GenBank under BioProject number PRJNA941175.

Conflict of interest: None declared.

Authors’ contributions: Study concept and design: Dortet; acquisition, analysis, or interpretation of data: Rezzoug, Emeraud, Rodriguez, Pawlotsky, Bonnin, Dortet; drafting of the manuscript: Rezzoug; critical revision of the manuscript for important intellectual content: all authors.

References

  • 1. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263-72. 10.1016/j.molmed.2012.03.003 [DOI] [PubMed] [Google Scholar]
  • 2. Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: a global scourge. Clin Infect Dis. 2018;66(8):1290-7. 10.1093/cid/cix893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Mojica MF, Bonomo RA, Fast W. B1-Metallo-beta-lactamases: where do we stand? Curr Drug Targets. 2016;17(9):1029-50. 10.2174/1389450116666151001105622 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Santé Publique France. Caractéristiques et évolution des souches d’entérobactéries productrices de carbapénémases (EPC) isolées en France, 2012-2020. https://www.santepubliquefrance.fr/import/caracteristiques-et-evolution-des-souches-d-enterobacteries-productrices-de-carbapenemases-epc-isolees-en-france-2012-2020; 2021. [accessed January 24th, 2024]
  • 5. Davin-Regli A, Pagès JM. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Front Microbiol. 2015;6:392. 10.3389/fmicb.2015.00392 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Dong X, Zhu M, Li Y, Huang D, Wang L, Yan C, et al. Whole-genome sequencing-based species classification, multilocus sequence typing, and antimicrobial resistance mechanism analysis of the Enterobacter cloacae complex in Southern China. Microbiol Spectr. 2022;10(6):e0216022. 10.1128/spectrum.02160-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Chavda KD, Chen L, Fouts DE, Sutton G, Brinkac L, Jenkins SG, et al. Comprehensive genome analysis of carbapenemase-producing Enterobacter spp.: new insights into phylogeny, population structure, and resistance mechanisms. MBio. 2016;7(6):e02093-16. 10.1128/mBio.02093-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Emeraud C, Petit C, Gauthier L, Bonnin RA, Naas T, Dortet L. Emergence of VIM-producing Enterobacter cloacae complex in France between 2015 and 2018. J Antimicrob Chemother. 2022;77(4):944-51. 10.1093/jac/dkab471 [DOI] [PubMed] [Google Scholar]
  • 9. Santella G, Pollini S, Docquier JD, Mereuta AI, Gutkind G, Rossolini GM, et al. Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621. J Clin Microbiol. 2010;48(11):4342-3. 10.1128/JCM.00614-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Bernabeu S, Bonnin RA, Dortet L. Comment on: Comparison of three lateral flow immunochromatographic assays for the rapid detection of KPC, NDM, IMP, VIM and OXA-48 carbapenemases in Enterobacterales. J Antimicrob Chemother. 2023;78(1):314-7. 10.1093/jac/dkac381 [DOI] [PubMed] [Google Scholar]
  • 11. Dortet L, Bréchard L, Poirel L, Nordmann P. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J Med Microbiol. 2014;63(5):772-6. 10.1099/jmm.0.071340-0 [DOI] [PubMed] [Google Scholar]
  • 12.European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance – Version 13.0. Växjö: EUCAST; 2023. Available from: v_13.0_Breakpoint_Tables.xlsx (live.com) [Google Scholar]
  • 13. Girlich D, Bonnin RA, Proust A, Naas T, Dortet L. Undetectable production of the VIM-1 carbapenemase in an Atlantibacter hermannii clinical isolate. Front Microbiol. 2021;12:741972. 10.3389/fmicb.2021.741972 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Moura A, Soares M, Pereira C, Leitão N, Henriques I, Correia A. INTEGRALL: a database and search engine for integrons, integrases and gene cassettes. Bioinformatics. 2009;25(8):1096-8. 10.1093/bioinformatics/btp105 [DOI] [PubMed] [Google Scholar]
  • 15. Potron A, Poirel L, Nordmann P. Plasmid-mediated transfer of the bla(NDM-1) gene in Gram-negative rods. FEMS Microbiol Lett. 2011;324(2):111-6. 10.1111/j.1574-6968.2011.02392.x [DOI] [PubMed] [Google Scholar]
  • 16. Pfeifer Y, Witte W, Holfelder M, Busch J, Nordmann P, Poirel L. NDM-1-producing Escherichia coli in Germany. Antimicrob Agents Chemother. 2011;55(3):1318-9. 10.1128/AAC.01585-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Girlich D, Dortet L, Poirel L, Nordmann P. Integration of the blaNDM-1 carbapenemase gene into Proteus genomic island 1 (PGI1-PmPEL) in a Proteus mirabilis clinical isolate. J Antimicrob Chemother. 2015;70(1):98-102. 10.1093/jac/dku371 [DOI] [PubMed] [Google Scholar]
  • 18. Sakamoto N, Akeda Y, Sugawara Y, Takeuchi D, Motooka D, Yamamoto N, et al. Genomic characterization of carbapenemase-producing Klebsiella pneumoniae with chromosomally carried bla NDM-1. Antimicrob Agents Chemother. 2018;62(12):e01520-18. 10.1128/AAC.01520-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kong LH, Xiang R, Wang YL, Wu SK, Lei CW, Kang ZZ, et al. Integration of the blaNDM-1 carbapenemase gene into a novel SXT/R391 integrative and conjugative element in Proteus vulgaris. J Antimicrob Chemother. 2020;75(6):1439-42. 10.1093/jac/dkaa068 [DOI] [PubMed] [Google Scholar]
  • 20. Bonnin RA, Poirel L, Naas T, Pirs M, Seme K, Schrenzel J, et al. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect. 2012;18(9):E362-5. 10.1111/j.1469-0691.2012.03928.x [DOI] [PubMed] [Google Scholar]
  • 21. Luo X, Yin Z, Zeng L, Hu L, Jiang X, Jing Y, et al. Chromosomal Integration of huge and complex bla NDM-carrying genetic elements in Enterobacteriaceae. Front Cell Infect Microbiol. 2021;11:690799. 10.3389/fcimb.2021.690799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Acman M, Wang R, van Dorp L, Shaw LP, Wang Q, Luhmann N, et al. Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene blaNDM. Nat Commun. 2022;13(1):1131. 10.1038/s41467-022-28819-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Campos JC, da Silva MJ, dos Santos PR, Barros EM, Pereira MO, Seco BM, et al. Characterization of Tn3000, a transposon responsible for bla NDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India. Antimicrob Agents Chemother. 2015;59(12):7387-95. 10.1128/AAC.01458-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Toleman MA, Biedenbach D, Bennett D, Jones RN, Walsh TR. Genetic characterization of a novel metallo-beta-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J Antimicrob Chemother. 2003;52(4):583-90. 10.1093/jac/dkg410 [DOI] [PubMed] [Google Scholar]
  • 25. Jolivet S, Couturier J, Vuillemin X, Gouot C, Nesa D, Adam M, et al. Outbreak of OXA-48-producing Enterobacterales in a haematological ward associated with an uncommon environmental reservoir, France, 2016 to 2019. Euro Surveill. 2021;26(21):2000118. 10.2807/1560-7917.ES.2021.26.21.2000118 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Eurosurveillance are provided here courtesy of European Centre for Disease Prevention and Control

RESOURCES